For the first time, many people living with chronic hepatitis B may have a functional cure at hand. The US Food and Drug Administration (FDA) has approved the Hibsago (bepirovirsen) injection, which studies show can keep the disease under control without the need for endless doses of antiviral drugs.

For the first time, many people living with chronic hepatitis B may have a functional cure at hand. The US Food and Drug Administration (FDA) has approved the Hibsago (bepirovirsen) injection, which studies show can keep the disease under control without the need for endless doses of antiviral drugs.